Medicament for liver regeneration and for treatment of liver failure
申请人:HELMHOLTZ-ZENTRUM FÜR INFEKTIONSFORSCHUNG GmbH
公开号:US10188682B2
公开(公告)日:2019-01-29
The present invention relates to the use of a compound which inhibits the activity of MKK4 as a medicament for the treatment of a patient suffering from an impaired liver function, to the use of a compound as a medicament for the treatment of liver failure, including acute/fulminant or chronic liver failure and/or for increasing the regeneration of liver tissue in a patient.
NH-1,2,3-triazole moieties are a part of the design of various biologically active compounds, pharmaceutical agents and functional materials. Unfortunately, the applications of this heterocycle are still underexplored due to the...